Answers are grounded in this paper and cite their sources.
Cefepime has a similar efficacy as carbapenems for the treatment of Enterobacter species bacteremia. Its use should be further explored as a carbapenem-sparing agent in this clinical scenario.
No takes yet. Share an insight, caveat, or question.
Siedner et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: